Stockscreener 앱 받기
4.49
0.88%
-0.04
Myriad Genetics Inc 주식(MYGN)의 최신 뉴스
Decoding Our DNA: The Human Impact Behind SNP Genotyping’s USD 19.48 Billion Growth by 2034 - GlobeNewswire Inc.
Little Excitement Around Myriad Genetics, Inc.'s (NASDAQ:MYGN) Revenues As Shares Take 27% Pounding - simplywall.st
Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating a 79% Potential Upside Amidst Challenging Metrics - DirectorsTalk Interviews
Published on: 2026-02-13 03:22:24 - mfd.ru
Why Myriad Genetics Inc. stock remains on buy listsOptions Play & Daily Stock Momentum Reports - mfd.ru
Myriad Genetics showcases prenatal screening breakthroughs at major conference - Traders Union
What’s the outlook for Myriad Genetics Inc.’s sectorDollar Strength & Daily Entry Point Trade Alerts - mfd.ru
Minimal Residual Disease Testing Market Poised for Rapid Growth - openPR.com
Can Myriad Genetics Inc scale operations efficientlyJuly 2025 PostEarnings & Intraday High Probability Setup Alerts - baoquankhu1.vn
Why Analysts See The Myriad Genetics (MYGN) Story Shifting After The New $7 Target - Yahoo Finance
Myriad Genetics, Inc. (NASDAQ:MYGN) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Does Myriad Genetics (NASDAQ:MYGN) Have A Healthy Balance Sheet? - simplywall.st
Responsive Playbooks and the MYGN Inflection - Stock Traders Daily
Esoteric Testing Research Report 2026 - GlobeNewswire Inc.
Parp Inhibitor Biomarkers Market Generated Opportunities, - openPR.com
Buy Signal: Does Myriad Genetics Inc have pricing powerM&A Rumor & Weekly Momentum Picks - baoquankhu1.vn
Myriad Genetics Unveils Commercialization Roadmap For Precise MRD Assay - Nasdaq
Myriad Genetics, Inc. Advances Mrd Commercialization Timeline, Bolstered by New Study Data - marketscreener.com
Myriad Genetics (MYGN) Outlines Launch Plan for Precise MRD Assa - GuruFocus
Myriad Genetics to launch Precise MRD cancer test in March 2026 - Investing.com
Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data - The Manila Times
Myriad Genetics Announces Commercial Launch of Precise MRD™ Assay for Enhanced Cancer Detection and Monitoring - Quiver Quantitative
Myriad cancer DNA test detects signals at 1-in-a-million - stocktitan.net
Earnings Risk: Whats the outlook for Myriad Genetics Incs sectorBear Alert & Free Verified High Yield Trade Plans - baoquankhu1.vn
Understanding the Setup: (MYGN) and Scalable Risk - Stock Traders Daily
Should I hold or sell Myriad Genetics Inc. nowJuly 2025 Sector Moves & Fast Gaining Stock Reports - mfd.ru
Carrier Screening Market with Insights from Abbott - openPR.com
Myriad Genetics (NASDAQ:MYGN) Downgraded by Zacks Research to Strong Sell - MarketBeat
Myriad Genetics (NASDAQ:MYGN) Stock Price Down 6.5%Time to Sell? - MarketBeat
Momentum Shift: Does LARK stock benefit from AI growth2025 Price Momentum & Verified High Yield Trade Plans - baoquankhu1.vn
Myriad Genetics, Inc. (MYGN) Stock Analysis: Uncovering a 36.50% Potential Upside in the Diagnostics Sector - DirectorsTalk Interviews
Volume Summary: Is now the right time to enter Myriad Genetics IncMarket Sentiment Report & Fast Gaining Stock Reports - baoquankhu1.vn
What is Myriad Genetics Incs book value per share2025 Market Outlook & Daily Profit Focused Stock Screening - baoquankhu1.vn
MYRIAD GENETICS Q4 2025 Earnings Preview: Recent $MYGN Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Market Review: Can Myriad Genetics Inc. stock double in next 5 yearsOptions Play & Long-Term Safe Investment Ideas - Bộ Nội Vụ
TEM's Collab for Oncology Patient Population Is Gaining Attention - sharewise.com
The Technical Signals Behind (MYGN) That Institutions Follow - Stock Traders Daily
Myriad Genetics forecasts 2026 revenue growth of 6% to $870 million - Investing.com Canada
Myriad Genetics Reports Preliminary Q4 Revenue; Issues 2026 Guidance - Nasdaq
Myriad Genetics announces select preliminary fourth quarter and full year 2025 financial results and introduces full year 2026 financial guidance - marketscreener.com
Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance - The Manila Times
Myriad Genetics Announces Select Preliminary Fourth Quarter And Full Year 2025 Financial Results And Introduces Full Year 2026 Financial Guidance - TradingView — Track All Markets
About Us - FinancialContent
Myriad Genetics, Inc. (NASDAQ:MYGN) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Why Myriad Genetics Inc. stock is in analyst buy zoneJuly 2025 Institutional & Target Return Focused Stock Picks - ulpravda.ru
What Analysts Think Is Shaping The Story For Myriad Genetics (MYGN) Now - Yahoo Finance
Can Myriad Genetics Inc. stock outperform in 2025 bull market2025 Short Interest & Growth-Oriented Investment Plans - ulpravda.ru
Is Myriad Genetics Inc. (MYD) stock a good hedge against inflationJuly 2025 Highlights & Capital Protection Trading Alerts - Улправда
Will Myriad Genetics Inc. stock benefit from infrastructure spending2025 Geopolitical Influence & Verified Trade Idea Suggestions - Улправда
Can Myriad Genetics Inc. (MYD) stock surprise with quarterly resultsQuarterly Investment Review & Consistent Return Strategy Ideas - Улправда
Clinical Laboratory Services Market is expected to reach US$ - openPR.com
Myriad Genetics (NASDAQ:MYGN) Stock Passes Above 200 Day Moving AverageHere's Why - MarketBeat
Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference - Sahm
Is Myriad Genetics Inc a good long term investmentMid Cap Growth Trends & Free Discover Massive Upside Stocks - earlytimes.in
The Truth About Myriad Genetics Inc: Is This DNA Stock a Sleeper Goldmine or Just Overhyped? - AD HOC NEWS
What analysts say about Myriad Genetics Inc stockPrice Gap Trading Strategies & Free Unmatched Market Gains - earlytimes.in
Should Myriad Genetics stock stay in your portfolio right now? - MSN
Myriad Genetics Inc Stock Analysis and ForecastHealthcare Stock Analysis & Small Investment Portfolio Tips - earlytimes.in
Precision Trading with Myriad Genetics Inc. (MYGN) Risk Zones - Stock Traders Daily
0.00%
1.13%
자본화:
|
볼륨(24시간):